JGC
HIMS icon

J. Goldman & Co’s Hims & Hers Health HIMS Stock Holding History

J. Goldman & Co’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-223,955
Closed -$4.52M – 522
2024
Q2 		$4.52M Buy
+223,955
New +$3.73M 0.13% 181
2023
Q4 		– Sell
-70,283
Closed -$442K – 394
2023
Q3 		$442K Buy
+70,283
New +$523K 0.02% 287
2023
Q2 		– Sell
-62,084
Closed -$616K – 426
2023
Q1 		$616K Sell
62,084
-1,062,667
-94% -$9.31M 0.02% 253
2022
Q4 		$7.21M Buy
1,124,751
+556,824
+98% +$3.17M 0.35% 80
2022
Q3 		$3.17M Sell
567,927
-1,037,829
-65% -$6.25M 0.15% 163
2022
Q2 		$7.27M Buy
+1,605,756
New +$6.85M 0.35% 76

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

J. Goldman & Co's HIMS Position: Q3 2024 in Review

J. Goldman & Co sold out of Hims & Hers Health (HIMS) in Q3 2024, closing a stake of 223,955 shares — an estimated $4.52M sold.

J. Goldman & Co first reported a position in HIMS in Q2 2022 and held it in 6 quarters. The position peaked at $7.27M in Q2 2022. 308 funds tracked by Wall St. Rank hold HIMS as of Q3 2024.

  • J. Goldman & Co reported no remaining Hims & Hers Health position as of Q3 2024 after selling out during the quarter.
  • J. Goldman & Co sold 223,955 Hims & Hers Health shares in Q3 2024, an estimated $4.52M.
  • J. Goldman & Co first reported a position in Hims & Hers Health in Q2 2022 and held it in 6 quarters.
  • J. Goldman & Co's Hims & Hers Health position peaked at $7.27M in Q2 2022.
  • 308 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2024.

Based on J. Goldman & Co's 13F filing for Q3 2024, filed 14 Nov 2024.